Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Septic Arthritis Market Research Report Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Forecast till 2030


ID: MRFR/Pharma/3183-HCR | 110 Pages | Author: Rahul Gotadki| April 2024

Market Synopsis of Septic Arthritis Market


The Septic Arthritis Market is anticipated to reach USD 69,448.42 Million by 2030 at 2.10% CAGR during the forecast period 2022-2030.Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.


The septic arthritis market is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the septic arthritis market.


Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the septic arthritis market. Fierce competition among key market players acts as a barrier for the new entrants in the septic arthritis market.


Segments    


The septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.


On the basis of diagnosis, septic arthritis market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.


On the basis of treatment, the septic arthritis market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.


On the basis of indication, the septic arthritis market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.


On the basis of end user, the septic arthritis market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.



FIGURE 1: Global Septic Arthritis Market by Region, 2016 (%) Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Research Methodology Global Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation Regional Analysis of theSeptic Arthritis Market        


America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.


Europe is the second largest septic arthritis market owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the septic arthritis market growth.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.


Key Players in the Septic Arthritis Market    


Some of the key players in the septic arthritis market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.).


Intended Audience



  • Arthritis Drug Manufacturers

  • Arthritis Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 

Report Attribute/Metric Details
  Market Size   2030: USD 69,448.42 Million
  CAGR   2.10% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, Indication, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers ·  Increasing prevalence of chronic diseases·  Availability of cost effective treatment·  Extensive research and development activities in internal medicine·  Increasing demand for the new drugs for the treatment of septic arthritis
 

Frequently Asked Questions (FAQ) :

The septic arthritis market CAGR would be 2.10% during the forecast period.

The septic arthritis market report has joint fluid analysis, blood tests, imaging, and others as a part of diagnostic segmentation.

The septic arthritis market report includes treatments like antibiotics, aspiration of the joint, surgery, and others.

The Americas would lead the septic arthritis market.

The APAC region would be the fastest-growing septic arthritis market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization